Eledon Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Eledon Pharmaceuticals, Inc. (ELDN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.50 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-19
- Eledon Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2014-09-30 was 218.42K shares.
- Eledon Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 2.50M shares, a 301.13% increase from fiscal 2024.
- Eledon Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 622.00K shares, a 94.36% decline from fiscal 2023.
- Eledon Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 11.03M shares, a 769.80% increase from fiscal 2022.
- Eledon Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 1.27M shares, a 80.37% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | 2.50M shares 10-K · filed 2026-03-19 | ||
| 2024-12-31 | 622.00K shares 10-K · filed 2026-03-19 | ||
| 2023-12-31 | 11.03M shares 10-K/A · filed 2025-08-14 | ||
| 2022-12-31 | 1.27M shares 10-K/A · filed 2024-08-19 | ||
| 2021-12-31 | 702.84K shares 10-K · filed 2023-03-30 | ||
| 2020-12-31 | 2.19M shares 10-K · filed 2022-03-24 | ||
| 2019-12-31 | 42.24K shares 10-K · filed 2021-03-31 | ||
| 2018-12-31 | 267.95K shares 10-K · filed 2019-03-28 | ||
| 2017-12-31 | 595.80K shares 10-K · filed 2019-03-28 | ||
| 2016-12-31 | 13.05K shares 10-K · filed 2018-04-02 | 324.90K shares 10-K · filed 2017-03-03 | |
| 2015-12-31 | 996.85K shares 10-K · filed 2017-03-03 | ||
| 2014-12-31 | 1.04M shares 10-K · filed 2017-03-03 | ||
| 2014-09-30 | 218.42K shares 10-Q · filed 2014-11-13 | ||
| 2013-12-31 | 786.54K shares 10-K · filed 2016-03-10 | ||
| 2012-12-31 | 99.13K shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |